{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:02:27Z","timestamp":1787238147221,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ygyno.2022.08.023","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T01:17:39Z","timestamp":1663118259000},"page":"283-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Splenectomy at the time of primary or interval cytoreductive surgery for epithelial ovarian carcinoma: A review of outcomes"],"prefix":"10.1016","volume":"167","author":[{"given":"Shannon K.","family":"Rush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany F.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandi S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan F.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Niaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2022.08.023_bb0005","author":"U.S. Cancer Statistics Working Group"},{"key":"10.1016\/j.ygyno.2022.08.023_bb0010","series-title":"Key Statistics for Ovarian Cancer","author":"Team TACS medical and editorial content","year":"2020"},{"issue":"5","key":"10.1016\/j.ygyno.2022.08.023_bb0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a Meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2022.08.023_bb0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ygyno.2022.08.023_bb0025","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S1470-2045(18)30566-7","article-title":"Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials","volume":"19","author":"Vergote","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2022.08.023_bb0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2013.06.017","article-title":"Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of gynecologic oncology group (GOG) 182","volume":"130","author":"Rodriguez","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.08.023_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jviscsurg.2016.04.013","article-title":"Medical complications following splenectomy","volume":"153","author":"Buzel\u00e9","year":"2016","journal-title":"J. Visc. Surg."},{"key":"10.1016\/j.ygyno.2022.08.023_bb0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/gyno.1995.1218","article-title":"Splenectomy as part of Cytoreductive surgery for ovarian carcinoma","volume":"58","author":"Nicklin","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.08.023_bb0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ygyno.2006.03.028","article-title":"Splenectomy as part of cytoreductive surgery in ovarian cancer","volume":"102","author":"Magtibay","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.08.023_bb0050","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.2147\/CMAR.S172687","article-title":"Splenectomy during cytoreductive surgery in epithelial ovarian cancer","volume":"10","author":"Sun","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.ygyno.2022.08.023_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3802\/jgo.2016.27.e62","article-title":"Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer","volume":"27","author":"Xiang","year":"2016","journal-title":"J. Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2022.08.023_bb0060","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/IGC.0b013e3182571479","article-title":"Splenectomy as part of primary cytoreductive surgery for advanced ovarian cancer: a retrospective cohort study","volume":"22","author":"Zapardiel","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2022.08.023_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ygyno.2005.08.036","article-title":"Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer","volume":"100","author":"Eisenkop","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.08.023_bb0070","series-title":"Current Diagnosis and Treatment: Surgery","article-title":"Spleen","author":"Doherty","year":"2014"},{"key":"10.1016\/j.ygyno.2022.08.023_bb0075","author":"Diseases NC for I and R. Recommended Adult Immunization Schedule for ages 19 years or older, United States"},{"key":"10.1016\/j.ygyno.2022.08.023_bb0080","doi-asserted-by":"crossref","first-page":"676.e1","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.08.023_bb0085","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest."},{"issue":"6","key":"10.1016\/j.ygyno.2022.08.023_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and efficacy of Apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial","volume":"3","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2022.08.023_bb0095","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archsurg.1978.01370190030004","article-title":"Thromboembolic risk of postsplenectomy thrombocytosis","volume":"113","author":"Boxer","year":"1978","journal-title":"Arch. Surg."},{"key":"10.1016\/j.ygyno.2022.08.023_bb0100","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1002\/ajh.26137","article-title":"Extreme thrombocytosis in low-risk essential thrombocythemia: retrospective review of vascular events and treatment strategies","volume":"96","author":"Tefferi","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.ygyno.2022.08.023_bb0105","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1097\/IGC.0b013e3182a0fa66","article-title":"Management of pancreatic fistulas after a splenectomy as part of cytoreductive surgery for ovarian cancer","volume":"23","author":"Kato","year":"2013","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822005777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822005777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:04:28Z","timestamp":1758773068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822005777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0090825822005777"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.08.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splenectomy at the time of primary or interval cytoreductive surgery for epithelial ovarian carcinoma: A review of outcomes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}